STUDIES ON TOXIC MACULOPATHIES USING THE VISION MONITOR
Metrovision is proud to contribute with its equipments to clinical research in ophthalmology and thanks all the researchers for their trust and confidence.
2006_Cussenot_Champ_visuel_et_ERG_multifocal_suivi_des_APS.pdf
2007_Guillet_Rétinopathie_aux_APS.pdf
2011_Nebbioso_Visual_field_and_MfERG_in_patient_on_HCQ_therapy.pdf
2012_Bora_MfERG_in_patient_on_HCQ_therapy.pdf
2015_Debellemaniere_MfERG_and_HCQ.pdf
2015_Jaumouille_Maculopathies_toxiques_au_plaquénil.pdf
2015_Lepoittevin_Intérêt_comparé_imagerie_et_MfERG_pour_le_suivi_des_APS.pdf
2016_Guepratte_Comment_surveiller_un_traitement_par_APS.pdf
2017_Fardeau_Depistage_Maculopathie_aux_APS.pdf
2017_Paulose_HCQ_toxicity.pdf
2018_Arndt_MERG_in_antimalarial_retinal_toxicity.pdf
2018_Guiot_Retinopathie_aux_APS.pdf
2019_Arndt_MfERG_and_adaptive_optics_in_patients_treated_with_HCQ.pdf
2019_Fardeau_Maculopathie_toxique_par_APS.pdf
2019_Ghroud_Champ_visuel_et_ERG_multifocal_dans_APS.pdf
2019_Messiant_Maculopathie_APS_sujet_asiatique.pdf
2020_Roy_Risk_of_retinopathy_in_Indian_patients_using_hydroxychloroquine.pdf